Literature DB >> 16243849

Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of colorectal cancer: 16 year, prospective, follow-up study.

Isis Dove-Edwin1, Peter Sasieni, Joanna Adams, Huw J W Thomas.   

Abstract

OBJECTIVE: To determine to what extent individuals with various family histories of colorectal cancer (from one to three or more affected first degree relatives) benefit from colonoscopic surveillance.
DESIGN: Prospective, observational study of high risk families, followed up over 16 years.
SETTING: Tertiary referral family cancer clinic in London. PARTICIPANTS: 1678 individuals from families registered with the clinic. Individuals were classified according to the strength of their family history: hereditary non-polyposis colorectal cancer (if they fulfilled the Amsterdam criteria), and one, two, or three affected first degree relatives (moderate risk).
INTERVENTIONS: Colonoscopy was initially offered at five year intervals or three year intervals if an adenoma was detected. MAIN OUTCOME MEASURES: The incidence of adenomas with high risk pathological features or cancer. This was analysed by age, the extent of the family history, and findings on previous colonoscopies. The cohort was flagged for cancer and death. Incidence of colorectal cancer and mortality during over 15,000 person years of follow-up were compared with those expected in the absence of surveillance.
RESULTS: High risk adenomas and cancer were most common in families with hereditary non-polyposis colorectal cancer (on initial colonoscopy 5.7% and 0.9%, respectively). In the families with moderate risk, these findings were particularly uncommon under age 45 (1.1% and 0%) and on follow-up colonoscopy if advanced neoplasia was absent initially (1.7% and 0.1%). The incidence of colorectal cancer was substantially lower-80% in families with moderate risk (P = 0.00004), and 43% in families with hereditary non-polyposis colorectal cancer (P = 0.06)-than the expected incidence in the absence of surveillance when the family history was taken into account.
CONCLUSIONS: Colonoscopic surveillance reduces the risk of colorectal cancer in people with a strong family history. This study confirms that members of families with hereditary non-polyposis colorectal cancer require surveillance with short intervals. Individuals with a lesser family history may not require surveillance under age 45, and if advanced neoplasia is absent on initial colonoscopy, surveillance intervals may be lengthened. This would reduce the demand for colonoscopic surveillance.

Entities:  

Mesh:

Year:  2005        PMID: 16243849      PMCID: PMC1283179          DOI: 10.1136/bmj.38606.794560.EB

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  24 in total

Review 1.  Colon cancer screening.

Authors:  R W Burt
Journal:  Gastroenterology       Date:  2000-09       Impact factor: 22.682

2.  Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence.

Authors:  F Citarda; G Tomaselli; R Capocaccia; S Barcherini; M Crespi
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

3.  Yield from colonoscopic screening in people with a strong family history of common colorectal cancer.

Authors:  D J Dowling; D J St John; F A Macrae; J L Hopper
Journal:  J Gastroenterol Hepatol       Date:  2000-08       Impact factor: 4.029

Review 4.  Genetic susceptibility to non-polyposis colorectal cancer.

Authors:  H T Lynch; A de la Chapelle
Journal:  J Med Genet       Date:  1999-11       Impact factor: 6.318

5.  Adenoma prevalence and cancer risk in familial non-polyposis colorectal cancer.

Authors:  G Lindgren; A Liljegren; E Jaramillo; C Rubio; A Lindblom
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

6.  Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer.

Authors:  H J Järvinen; M Aarnio; H Mustonen; K Aktan-Collan; L A Aaltonen; P Peltomäki; A De La Chapelle; J P Mecklin
Journal:  Gastroenterology       Date:  2000-05       Impact factor: 22.682

7.  New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.

Authors:  H F Vasen; P Watson; J P Mecklin; H T Lynch
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

8.  Family studies in cancer of the colon and rectum.

Authors:  E Lovett
Journal:  Br J Surg       Date:  1976-01       Impact factor: 6.939

9.  Proximal adenomas in hereditary non-polyposis colorectal cancer are prone to rapid malignant transformation.

Authors:  F E M Rijcken; H Hollema; J H Kleibeuker
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

10.  Results of screening colonoscopy among persons 40 to 49 years of age.

Authors:  Thomas F Imperiale; David R Wagner; Ching Y Lin; Gregory N Larkin; James D Rogge; David F Ransohoff
Journal:  N Engl J Med       Date:  2002-06-06       Impact factor: 91.245

View more
  56 in total

1.  Risk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinoma.

Authors:  Andreas Obermair; Danny R Youlden; Joanne P Young; Noralane M Lindor; John A Baron; Polly Newcomb; Susan Parry; John L Hopper; Robert Haile; Mark A Jenkins
Journal:  Int J Cancer       Date:  2010-12-01       Impact factor: 7.396

2.  Patients at risk of familial colorectal cancer.

Authors:  Hanns-Peter Knaebel; Peter Kienle
Journal:  BMJ       Date:  2005-11-05

3.  Detection of colorectal neoplasia by colonoscopy in average-risk patients age 40-49 versus 50-59 years.

Authors:  Matthew N Thoma; Fernando Castro; Mushfeka Golawala; Ren Chen
Journal:  Dig Dis Sci       Date:  2011-02-01       Impact factor: 3.199

Review 4.  Prophylactic surgery in Lynch syndrome.

Authors:  V Celentano; G Luglio; G Antonelli; R Tarquini; L Bucci
Journal:  Tech Coloproctol       Date:  2011-02-02       Impact factor: 3.781

5.  Lynch Syndrome in high risk Ashkenazi Jews in Israel.

Authors:  Yael Goldberg; Inbal Kedar; Revital Kariiv; Naama Halpern; Morasha Plesser; Ayala Hubert; Luna Kaduri; Michal Sagi; Israela Lerer; Dvorah Abeliovich; Tamar Hamburger; Aviram Nissan; Hanoch Goldshmidt; Irit Solar; Ravit Geva; Hana Strul; Guy Rosner; Hagit Baris; Zohar Levi; Tamar Peretz
Journal:  Fam Cancer       Date:  2014-03       Impact factor: 2.375

Review 6.  ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.

Authors:  Sapna Syngal; Randall E Brand; James M Church; Francis M Giardiello; Heather L Hampel; Randall W Burt
Journal:  Am J Gastroenterol       Date:  2015-02-03       Impact factor: 10.864

Review 7.  Diagnosis and management of hereditary colorectal cancer syndromes: Lynch syndrome as a model.

Authors:  Henry T Lynch; Jane F Lynch; Thomas A Attard
Journal:  CMAJ       Date:  2009-08-04       Impact factor: 8.262

8.  Development and validation of an instrument to measure the impact of genetic testing on self-concept in Lynch syndrome.

Authors:  M J Esplen; N Stuckless; S Gallinger; M Aronson; H Rothenmund; K Semotiuk; J Stokes; C Way; J Green; K Butler; H V Petersen; J Wong
Journal:  Clin Genet       Date:  2011-10-03       Impact factor: 4.438

9.  Referral patterns of Indiana oncologists for colorectal cancer genetic services.

Authors:  Jessica Claybrook; Cindy Hunter; Leah Flury Wetherill; Gail H Vance
Journal:  J Cancer Educ       Date:  2010-03       Impact factor: 2.037

10.  Mutation spectrum in HNPCC in the Israeli population.

Authors:  Yael Goldberg; Rinnat M Porat; Inbal Kedar; Chen Shochat; Michal Sagi; Avital Eilat; Suzan Mendelson; Tamar Hamburger; Aviram Nissan; Ayala Hubert; Luna Kadouri; Eli Pikarski; Israela Lerer; Dvorah Abeliovich; Dani Bercovich; Tamar Peretz
Journal:  Fam Cancer       Date:  2008-04-04       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.